Trials / Completed
CompletedNCT01710722
The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.
Detailed description
Three treatments are compared to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol. 1\) Leptin A-200 injections daily with 2 inactive pills taken three times a day, 2) Caffeine with ephedrine pills taken 3 times a day with an inactive injection daily and 3) Both Leptin A-200 injections daily and caffeine with ephedrine pills taken three times a day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | caffeine and ephedrine | Caffeine 200 mg tablets and ephedrine HCl 25 mg tablets three times a day with placebo leptin A-200 subcutaneously once daily. |
| DRUG | Leptin A | Leptin A-200 20 mg subcutaneously once daily and placebo tablets of caffeine and ephedrine three times a day. |
| DRUG | caffeine, ephedrine, and leptin A | Caffeine 200 mg tablets and ephedrine HCl tablets 25 mg three times a day with leptin A-200 20 mg subcutaneously once daily. |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2002-02-01
- Completion
- 2002-02-01
- First posted
- 2012-10-19
- Last updated
- 2015-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01710722. Inclusion in this directory is not an endorsement.